Sparta Biomedical

spartabiomedical.com

Sparta Biomedical is pioneering the development of Galene, a chemically engineered cartilage platform aimed at treating osteoarthritis and restoring mobility. Their innovative approach addresses cartilage degeneration through the creation of cartilage-like implants for various joints, including the knee, shoulder, and hip. The company differentiates itself by combining advanced chemistry, mechanical engineering, and biology to provide immediate pain relief and restore full range of motion for patients. With a strong leadership team experienced in pharma and medtech, Sparta Biomedical is positioned to make a significant impact in the orthopedic market, addressing a global issue that affects over 651 million people suffering from knee osteoarthritis.